Metlife (MET-PA) EBITDA (2009 - 2026)

Metlife's EBITDA history runs 18 years deep, the most recent figure standing at $42.0 million for Q1 2026.

• In Q1 2026, EBITDA fell 98.58% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $10.3 billion (down 22.0% YoY), while the FY2025 annual figure was $22.6 billion, up 6.05% from the prior year.
• EBITDA was $42.0 million for Q1 2026 at Metlife, down from $5.9 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $5.9 billion in Q4 2025 to a low of -$7.2 billion in Q2 2022.
• Historically, EBITDA has averaged $978.4 million across 5 years, with a median of $1.1 billion in 2025.
• The sharpest annual moves came in 2022 and 2025: EBITDA slumped 334.7% in 2022, then jumped 10327.27% in 2025.
• A 5-year view of EBITDA shows it stood at $4.5 billion in 2022, then climbed by 20.21% to $5.4 billion in 2023, then grew by 0.73% to $5.4 billion in 2024, then increased by 9.6% to $5.9 billion in 2025, then tumbled by 99.29% to $42.0 million in 2026.
• The last three EBITDA figures came in at $42.0 million (Q1 2026), $5.9 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.